期刊文献+

尿毒症患者发生颈动脉重构的危险因素分析

Analysis on the risk factors of carotid reconstruction a uremia patient may face
下载PDF
导出
摘要 目的采用颈动脉内膜-中层厚度来评价颈动脉重构程度,分析尿毒症患者发生颈动脉重构的危险因素。方法采用回顾性队列研究,选取维持性血液透析的尿毒症患者120例,按有无动脉重构分为颈动脉重构组(A组,n=74例),非颈动脉重构组(B组,n=46例),分别评价两组患者年龄、血压、吸烟、脉搏波传导速度及生化指标。结果采用二分类的非条件Logistic回归多因素方法,筛选出5个危险因素:收缩压(OR=1.85)、吸烟(OR=1.77)、年龄(OR=1.74)、甘油三酯(OR=1.08)、总胆固醇(OR=1.05),上述指标回归系数均为正值,差异有统计学意义(P〈0.05)。结论收缩压、吸烟、年龄、甘油三酯、总胆固醇可能是尿毒症患者发生颈动脉重构的危险因素。 Objective To analyze the risk factors of carotid reconstruction in end-stage renal disease (EDRS) patients under hemodialysis may face, adopt carotid artery intima-media thickness to evaluate the degree of carotid reconstruction. Methods 120 EDRS patients under hemodialysis were divided into the two groups- A group (74 patients with artery remodeling group) and B group (46 patients with non-artery remodeling group). The evaluation was made with following criteriaage, blood pressure, smoking, and biochemical indicators. Results Using two categories of rion-condition logistic regression multivariate methods, filter out the five risk factors as systolic blood pressure (OR = 1.85), smoking (OR = 1.77), age (OR = 1.74), triglyceride (OR = 1.08), and the total cholesterol (OR = 1.05). The overall regression coefficients reflected positive (P〈 0.05). Conclusion The systolic blood pressure, smoking, age, triglyceride, and the total cholesterol may he the risk factors, interrelated with EDRS patients' carotid reconstruction.
出处 《中国急救复苏与灾害医学杂志》 2010年第12期1115-1117,共3页 China Journal of Emergency Resuscitation and Disaster Medicine
关键词 尿毒症 颈动脉 重构 危险因素 End-stage renal disease Carotid Reconstruction Risk factors
  • 相关文献

参考文献11

  • 1Collado S, Coil E, Deulofeu R, et al. Prevalence of cardiovascular disease in uraemia and relevance of cardiovascular risk factors. Nefrologia, 2010, 30 (3):342-348.
  • 2Middleton JP, Pun PH. Hypertension, chronic kidney disease, and the development of cardiovascular risk: a joint primacy. Kidney lnt, 2010, 77(9): 753-755.
  • 3Mizobuchi M, Towler D, Slatopolsky E. Vascular calcification: the killer of patients with chronic kidney disease. J Am Soe Nephrol, 2009, 20(7): 1453-1464.
  • 4Riccioni G, D Orazio N, Seotti,Petruzzelli R. Circulating plasma antioxidants, inflammatory, markers and asymptomatic carotid atberosclerosis in end-stage renal disease patients: a case control study, lnt J Immunopathol Pharmacol, 2010, 23(1):327-334.
  • 5Mataradzija A, Resic H, Rasic S, et al. Risk factors for development of cardiovascular complications in patients with chronic: renal disease and diabetic nephropathy. Bosn J Basic Med Sci, 2010, 10 Suppl 1:S44-50.
  • 6Vaziri ND. Causes of dysregulation of lipid metabolism in chronic renal failure. Semin Dial, 2009, 22(6):644-651.
  • 7Krasniak A, Drozdz M, Pasowicz M. Factors involved in vascular calcification and atherosclerosis in maintenance haemodialysis patients. Nephrol Dial Transplant, 2007, 22(2):515-521.
  • 8Ito H, Komatsu Y, Mifune M, et ah The estimated GFR, but not the stage of diabetic nephropathy graded by thc urinary albumin excretion, is associated with the carotid intima-media thickness in patients with type 2 diabetes mellitus: a cross-sectional study. Cardiovasc Diabetol, 2010,15(9):18.
  • 9Kawagishi T, Nishizawa Y, Konishi T. High-resolution B-mode uhrasonography in evaluation of atherosclerosis in uremia. Kidney Int, 1995, 48(3):820-826.
  • 10Nakamura S, Ishibashi-ueda D, Nizuma S, et al.Coronary calcification in patients with chronic kidney disease and coronary artery disease. Clin J Am Soc Nephrol, 2009, 4( 12): 1892-1900.

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部